CVS
NYSE · Health Care
Cvs Health Corp
$97.16
+2.17 (+2.28%)
CVS News30 articles
UnitedHealth's Optum Health Beats 2026 Profit Goal, Investors Eye 2027 Growth
Optum Health reported $2.486B in adjusted operating earnings for H1 2026, beating its full-year minimum target by 12%, but investors look to 2027 for sustained growth.
CVS Raises Guidance as Aetna Powers Q2 Beat
CVS Health raised its 2026 EPS outlook after a strong Q2, with Aetna contributing nearly all of the operating-profit increase. The stock rose in premarket trading.
Medicare Part D Subsidy Phaseout Poses Enrollment Risks for Standalone Plans
Centene (CNC) is most exposed to Medicare Part D subsidy phaseout, with 90% of its drug plan members in standalone plans. The end of the $3.6B demo could trigger enrollment shifts.
Medicare Part D Subsidy Phaseout Widens Insurer Pricing Gap
CMS plans to end temporary Part D assistance after 2026, with 2027 bids up 23.7%. Insurers like Centene face enrollment risk as pricing gaps widen.
TrumpRx Program Shows Limited Big Pharma Impact
TrumpRx's 79 presidential deals cover just 10% of branded drugs from 17 pharma firms, far below the touted 800. Major drugs like Ibrance and Biktarvy are excluded, limiting investor risk.
Abbott Leads Healthcare Surge as Insurers Show Mixed Results
Abbott Laboratories surged 10.9% despite a modest earnings beat, while UnitedHealth rose 2.6% on a larger beat. The healthcare sector ETF XLV gained 2.2%.
Humana Stock Slides 3.6% as High Valuation Meets Earnings Reality Check
Humana shares dropped 3.6% on Thursday, giving back an initial 4.1% rise, as investors reassess the stock's premium valuation ahead of its July 29 earnings report.
UnitedHealth Stock at $429: Earnings Test Looms as Investors Eye $25 EPS Target
UnitedHealth stock trades up ahead of Q2 earnings, with the market pricing in a long-term EPS target of $25 by 2028. Analysts watch for margin improvements and Optum recovery.
AI-Driven Healthcare Fraud Surge Strains Insurers, Coverage Gaps Widen
AI is fueling healthcare fraud with fake medical records and bot calls, driving up costs and exposing coverage gaps as insurers scramble to adapt.
Amazon Ousts Walmart to Top Fortune 500, Reshaping Corporate Peeking Order
Amazon has claimed the top spot on the 2026 Fortune 500, ending Walmart's 13-year run and signaling a shift in corporate power driven by e-commerce, cloud computing, and healthcare.
Humana Shares Surge 11% on Medicare Advantage Optimism
Humana shares surged 11.27% on Friday amid renewed Medicare Advantage optimism after CVS raised its 2026 profit outlook, though concerns over Star Ratings and funding persist.
UnitedHealth Stock Rebounds on Easing Medical Costs and Raised Outlook
UnitedHealth shares rose 2.8% to $379.98, extending gains on easing medical-cost pressures. Q1 revenue hit $111.7B, and the company raised its full-year adjusted earnings outlook above $18.25/share.
Humana Stock Rally Tests Valuation as Profit Forecast Slips
Humana lowered its 2026 GAAP EPS forecast to at least $8.36, while its stock has surged over 25% in a month, pushing the P/E ratio above 26.
Blue Cross Blue Shield $2.67B Settlement Payouts Begin in May 2026
Blue Cross Blue Shield settlement payments start in May 2026 for eligible claimants in a $2.67 billion antitrust case. Payouts vary based on claims and premiums, with an estimated average of $333.
UnitedHealth Eases Prior Authorization Rules; UNH Shares Gain
UnitedHealth Group shares climbed 1% after the company announced it will eliminate prior authorization for 30% of services by 2026, including outpatient surgeries and diagnostic tests.
CVS Health Upgrades 2026 Profit View as Aetna Cost Controls Boost Q1 Results
CVS Health raised its 2026 profit outlook after a strong Q1, with revenue topping $100 billion and Aetna's medical benefit ratio improving to 84.6%. Shares surged 9%.
Cigna Exits ACA Market, 369,000 Members Need New Plans for 2027
Cigna Group will exit the ACA individual insurance market after 2026, affecting 369,000 members in 11 states who must find new coverage for 2027.
Blue Cross Blue Shield Settlement Payouts to Begin in May
Payments from the $2.67 billion Blue Cross Blue Shield antitrust settlement begin in May 2026 for eligible claimants who filed by November 2021.
UnitedHealth, Health Insurers Rally on Centene Profit Outlook Boost
UnitedHealth Group shares rose about 4% Tuesday after Centene lifted its profit outlook, fueling hopes that medical-cost pressures are easing for major insurers.
Futures Gain on Iran Ceasefire Extension; Tesla, Airlines in Focus
U.S. stock futures advanced Wednesday morning following an extension of the Iran ceasefire. Investors are monitoring oil prices and a busy earnings calendar featuring Tesla and United Airlines.
Stocks Retreat as Oil Surge, Fed Jitters Undercut Rally
Major U.S. equity indices turned lower Tuesday afternoon, surrendering morning advances as climbing crude prices and bond yields introduced fresh uncertainty. The S&P 500 declined 0.32% to 7,086.48.
UnitedHealth Shares Rally on Medicare Advantage Rate Decision Ahead of Q1 Report
UnitedHealth Group shares advanced following a finalized 2.48% increase to 2027 Medicare Advantage payment rates, which exceeds initial projections. The company is set to report first-quarter results on April 21 amid expectations for an earnings decline.
Salesforce Unveils AI Healthcare Agents, Stock Gains Amid Sector Competition
Salesforce introduced six new AI agents for healthcare workflows, with integrations from HealthEx, Verily, and Viz.ai. The company's stock climbed 3.8% as competitors AWS and Google Cloud announced similar healthcare AI platforms.
AWS Launches AI Platform to Automate Healthcare Administrative Tasks
Amazon's cloud division has unveiled Amazon Connect Health, an AI-driven platform aimed at reducing administrative burdens in healthcare by automating tasks like patient verification and clinical documentation. Early adopters report efficiency gains, with Amazon shares rising slightly on the news.
UnitedHealth Rallies Ahead of Key Medicare Decision
UnitedHealth Group shares closed 3.1% higher at $293.19 on Friday, marking a three-day rally. Investors are now focused on the upcoming final 2027 Medicare Advantage rate decision.
UnitedHealth Gains Amid Medicare Rate Uncertainty and ACA Investigations
UnitedHealth shares edged higher as investors monitored upcoming Medicare Advantage payment decisions and a House Republican probe into ACA insurers. The sector traded mixed.
UnitedHealth Dips After Hours as Medicare Rate Decision Looms
UnitedHealth shares edged lower in extended trading Monday as healthcare stocks underperformed the broader market. Investors are focused on upcoming Medicare Advantage reimbursement updates, with the final rates expected in early April.
Amgen Hits 52-Week Peak on Strong Earnings; Key Data, Dividend Date Ahead
Amgen shares surged 4.5% to a 52-week high of $384.32, fueled by robust quarterly results and a dividend declaration. Investors now await delayed U.S. jobs and inflation figures.
UnitedHealth Rallies 3% to Close Volatile Week; Medicare Advantage Outlook in Focus
UnitedHealth shares gained 3% Friday to $276.65, stabilizing after a turbulent period for managed-care stocks. Investors now await earnings from CVS Health and Humana next week for critical updates on Medicare Advantage trends.
Amgen Reaches 52-Week Peak on Friday; Investors Eye Inflation Data and Drug Pricing
Amgen shares surged 4.5% to close at $384.32 on Friday, achieving a new 52-week high. Market participants are monitoring upcoming U.S. inflation figures and developments in drug pricing.